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Abstract 
Asthma is a chronic lung disease with staggering disease burden in youth. Current literature 
suggests that maternal exposure to certain xenobiotic chemicals can affect developing offspring 
epigenetics, leading to a predisposition for asthma. Our previous study links polybrominated diphenyl 
ether congener 47 (PBDE-47), a chemical used as a flame-retardant within household products, with 
increased airway hyperresponsiveness (AHR). Of further concern is the potential influence of PBDE-47 in 
mice lung on the epigenetic alterations regulating asthma related genes that may play a role in 
pathogenesis, such as Tumor Necrosis Factor Alpha (TNFA) and Brain Derived Neurotrophic Factor 
(BDNF). This thesis tested the hypothesis that altered DNA methylation of key asthma related genes due 
to PBDE-47 exposure leads to modulation of gene transcription. 
In Chapter 1, I begin by introducing PBDEs, and discuss the role of altered DNA methylation in 
disease pathogenesis. The major genes studied in the experiment, Bdnf and Tnfa, are also detailed, and I 
discuss the effects that dysregulation of these key genes has on health. In Chapter 2, I observed there is 
no difference in gene expression and DNA methylation of Bdnf and Tnfa in mouse exposed to a single 
postnatal PBDE-47. In Chapter 3, I investigated the epigenetic effect of maternal PBDE-47 exposure on 
offspring’s airway reactivity and asthma phenotypic genes. This multi-dose experiment found increased 
gene expression and promoter demethylation for Bdnf and Tnfa in the mouse model.  
Overall, the completion of this research illuminates the epigenetic effects of exposure to PBDE-47 on 
asthma genes, and their connection with previously observed increased AHR. This study presents an 
innovative approach to observing the effect of PBDE-47 exposure on asthma risk through utilizing 
methylation profiling. While many previous studies look at direct adverse health effects, my approach 
demonstrates how PBDE-47 exposures have epigenetic effects in offspring of impacted mothers. 
Looking at in utero effects demonstrates that epigenetics underpins a mechanism of toxic action with 
PBDEs that would not be commonly seen in traditional animal experiments by establish a heritable 
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epigenetic model of toxic action of PBDEs on key genes related to the development of asthma in 
mammals. 
 
Official Readers 
Primary Reader:  Dr. Wan-Yee Tang, Associate Professor 
Secondary Reader:  Dr. Mark Kohr, Assistant Professor 
 
 
iv 
 
TABLE OF CONTENTS  
ABSTRACT ........................................................................................................................................... ii   
TABLE OF CONTENTS .......................................................................................................................... iv   
LIST OF TABLES  ................................................................................................................................... v 
LIST OF FIGURES  ................................................................................................................................ vi  
CHAPTER 1: Background ……................................................................................................................ 1   
1.1 Background on Polybrominated Diphenyl Ethers ...………………………………………….……………………………… 1  
1.2 Exposure Assessment and Epidemiology Studies of PBDEs …………………………..……………………………….… 1 
1.3 Known Health Effects of PBDE Exposure ………………………………………..…….............................................. 2  
1.4. Effect of PBDEs on Asthma Pathogenesis ……………………………………………….…....................................... 3  
1.5 New direction: Epigenetic Changes Associated with PBDE Exposures .……………..……………………………… 7  
CHAPTER 2: Effect of Single Dose Exposure on Offspring Asthma Associated Phenotypes .................. 10   
2.1 Abstract ...……………….…………………………………………………………………………………………………………………….. 10 
2.2 Introduction ………………………………………....…...…….………………………………………...................................... 10 
2.3 Materials and Methods ………...…………………………………………………………………….................................... 11  
2.4 Results ……………………………………………………..…………………………………………………………………………………….13 
CHAPTER 3: Effect of Multi Dose Exposures on Offspring Asthma Associated Phenotypes ................. 15  
3.1 Abstract ………………………….……………………………………………………….……………………………………………………. 15   
3.2 Introduction .……………………………….………………….…………….................................................................... 15 
3.3 Materials and Methods ……………………………………..………………………………………………………………….......... 16  
3.4 Results …………………………………………………………………………………………………………………………………………… 20   
CHAPTER 4:  CONCLUSIONS, IMPLICATIONS, AND FUTURE DIRECTIONS …………………………………….……. 31 
REFERENCES ……………………………………………………………………………………………………………………………………. 33  
RESUME ………………………………………………………………………………………………………………………………………….. 39 
v 
 
LIST OF TABLES   
Table 1:  Effect of single PBDE-47 dose on gene expression in Bdnf and Tnfa in mouse lungs ……………… 14 
Table 2:  Effect of single PBDE-47 dose on promoter methylation of Bdnf in mouse lungs ..………………… 14 
Table 3:  MSCPR primers for Tnfa and Bdnf ………………………………………………………………………………….……… 18 
Table 4:  qPCR primer list for RRBS genes …………………………………………………………………………………….……… 19 
Table 5:  Effect of multiple PBDE-47 doses and HDM on gene expression of Bdnf and Tnfa ………………… 22 
Table 6:  Effect of multiple PBDE-47 doses and HDM on Bdnf and Tnfa promoter methylation …………….23 
Table 7:  Effect of multiple PBDE-47 doses and HDM on gene expression of differentially methylated 
genes identified through RRBS ……………………………………………………………………………………………………..… 29-30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF FIGURES   
Figure 1:  Effect of maternal PBDE-47 exposure and adult HDM exposure on gene expression of Bdnf and 
Tnfa …................................................................................................................................................................ 21  
Figure 2:  Effect of maternal PBDE-47 exposure and adult HDM exposure on Bdnf and Tnfa promoter 
methylation ....................................................................................................................................................... 22 
Figure 3:  Effect of maternal PBDE-47 exposure and adult HDM exposure on mRNA level of differentially 
methylated genes identified through RRBS ................................................................................................. 27-28 
 
1 
 
CHAPTER 1:  Background  
 
1.1 Background on Polybrominated Diphenyl Ethers 
Polybrominated Diethyl Ethers, or PBDEs, are chemicals with a wide variety of industrial uses and 
have a large range of human health impacts. They are classified as persistent organic pollutants (POPs) 
due to their ability to bioaccumulate in the environment, and have been extensively studied in both 
experimental and epidemiologic settings. PBDEs can be chemically identified through their bromination 
pattern; they are organic hydrocarbon molecules with bromines attached to a minimum of 2 and 
maximum of 10 ether carbons (1). PBDEs in industry are most commonly used as flame retardants, and 
as a result, are ubiquitously present in many household products, particularly in the U.S. These products 
include, but are not limited to: plastics, furniture, upholstery, electrical equipment, electronic devices, 
and textiles (1). Commercial PBDEs are typically congers of penta-, octa-, or deca-PBDEs; the prefix 
referring to the number of attached bromines (1). However, the commercially used PBDEs contain 
mixtures of several lower brominated BDEs, which pose a greater health risk than pure versions of the 
higher brominated PBDEs (2). This increased hazard is because PBDEs with lower bromination have a 
greater tendency to bioaccumulate, due to their higher degree of fat solubility and hydrophobicity (2).  
While penta- and octa-PBDEs have been prohibited for commercial use since 2009 in the United 
States, deca-BDE usage remains prominent throughout the world (3). Additionally, many older products 
purchased before the ban of certain PBDE species still possess potentially harmful levels of penta- and 
octa-PBDEs, as it does not quickly degrade in the environment due to its long half-life (4).  
 
1.2 Exposure Assessment and Epidemiology Studies of PBDEs 
 Human exposure commonly occurs from inhalation and ingestion of dust containing PBDE (1, 
41). Another common pathway of PBDEs entering the human body is via ingestion of foods; particularly 
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in areas where PBDE contaminated products are disposed (3, 4). Disposal of PBDE contaminated 
products leads to contamination of potentially ingested plants, animals, or soil as the waste products 
degrade, leaving the PBDEs behind. Dermal absorption is also possible through from products that still 
contain PBDEs (1).   
While traditionally, other persistent organic pollutants attribute their exposure almost exclusively to 
ingestion through food exposure due to their tendency to bioaccumulate, PBDEs enter the human body 
primarily through dust residue from consumer products and furniture, giving them a reputation as a 
“indoor POP” (41). As a result of this near ubiquitous indoor exposure, over 98% of the U.S. population 
has some level of PBDE burden, with the 95th percentile of the population having a concentration of 
~291ng/g of PBDE, over 7 times the geometric mean PBDE-47 burden (41, 42). The burden is even more 
stark in the top 1% of exposures, where these subjects have ~3680ng/g, over 12 times the burden of 
those at the 95th percent (41).  It is also difficult to predict who may develop high blood serum levels of 
PBDE, due to only weak associations between normal predictors of exposures, such as race and 
socioeconomic status (43). However, it is known that PBDE burden is pronounced in children, as they are 
a subpopulation that spends the most time having their hands in their mouth, giving a direct pathway 
from PBDE contaminated products to digestion.   
 
1.3 Known Health Effects of PBDEs Exposure 
The most well known, albeit not fully understood, health effects attributable to exposure by PBDEs 
include endocrine disruption, developmental neuropathologies, and immune system disruption (5).  
However, there are several other less explored health implications of these chemicals, and their 
toxicodynamic mechanisms are just beginning to be understood. My research aimed to obtain a better 
understanding of the ways in which PBDEs contribute to the development of human disease by looking 
at ways in which PBDEs may lead to an asthmatic phenotype in mammals.   
The endocrine effects of PBDEs are amongst the most well studied outcomes of the chemical 
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exposure. Martin et al. found that PBDEs primarily cause reproductive toxicity by delaying onset of 
testicular descent and decreasing sperm count, along with an association with cryptorchidism (5). 
Exposure to endocrine disrupting chemicals (EDCs) has a medium to weak trend with sperm damage, 
spontaneous abortion, male reproductive tract issues, prostatitis, endometriosis, polycystic ovaries 
syndrome, and shortened lactation (5). PBDEs may also lead to elevated levels of T4 hormone produced 
by the thyroid, which can have notable effects on the metabolic activity in those exposed (6). Outside of 
the reproductive system, there has been evidence for PBDE induced neurobehavioral changes, 
neurodegenerative effects, and brain damage. While the mechanism, until recently, has been relatively 
unknown, the effect of inflammation and altered growth factors from PBDE exposure may provide an 
explanation for observed neurological phenomena associated with chemical exposure. This may have 
important implications in many neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and 
amyotrophic lateral sclerosis (8).  
PBDEs may also influence immune health. The production of several inflammatory cytokines species, 
which promote the inflammatory immune response, has been linked to PBDE exposure (9, 46). The 
inflammatory response increases blood flow to the exposed area, leading to greater white blood cell 
phagocytosis of pathogens and xenobiotics, but in excess may cause damage to tissue and hyper-
reactivity in many diseases. This modulated immune response has high variability between individuals, 
with unclear mechanism as to what stimulates its effect (47). Finally, PBDEs also show an association to 
many cancers through indirect mechanisms. TRKB is a receptor of BDNF, one of our genes of interest 
that is affected by PBDEs, and is highly expressed in many cancers. A 2012 study by Kimura et al. saw 
that having higher TRKB and BDNF lead to poor prognosis of patients with small cell lung cancer due to 
promotion of migration of TRKB overexpressing SC lung cancer cells (15).   
 
1.4 Effect of PBDEs on Asthma Pathogenesis 
The role of PBDEs in asthma remains unclear, with plenty of epidemiological evidence to 
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support a potential connection between PBDE exposure and asthma, but with no clear mechanism for 
asthma development. Over 300 million people worldwide experience asthma, and the rates of asthma 
development in children and young adults is increasing by approximately 5% every year (30). Asthma 
morbidity is a particular problem in the U.S., with over 22 million Americans having the disease (29). It is 
estimated that every year in the United States, asthma causes at least 15 million outpatient visits, 2 
million emergency room visits, and 500,000 full hospitalizations (29). Asthma patients experience a wide 
level of phenotypic expression, with many risk factors that may differentiate moderate vs. severe 
asthma symptoms. Dougherty and Fehy identified many factors that may lead to exacerbation of the 
respiratory symptoms of asthma, which include host response to viral infection, location of infections, 
airborne pollutants, cigarette smoke, medication non-compliance, psychosocial factors, co-morbidities, 
and deficiencies in epithelial cell production of anti-inflammatory products (29). They also mention that 
exacerbation events are more common amongst post-pubertal women, leading more adult women to 
experience acute asthma hospitalization than men (29). Additionally, there are greater amounts of acute 
asthma events amongst African Americans and Hispanic Americans unexplained by socioeconomic 
factors and asthma therapy options (29).  
Several other early-life xenobiotic exposures have a definitive link to childhood asthma. One of 
the better-characterized risk factors for developing childhood asthma is air pollution, with a variety of 
indoor and outdoor pollutants being known causes of asthma development in children. In the Kaiser air 
pollution (KAPPA) study in Atlanta, Georgia, they measured pollution levels of fine particulate matter 2.5 
(PM 2.5), NOx compounds, and CO levels at several residential locations within Atlanta. The KAPPA study 
found that there was a significant difference in asthma risk in children for every quintile increase for 
each of the studied air pollutants, with the risk in asthma development being most pronounced going 
from the first to the second quintile, and having a leveling off of risk in the further quintiles (33). 
Rumachev et al. looked at several volatile organic compounds that were hypothesized to have 
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association with asthma.  While benzene alone was not a significant risk factor in asthma, combinations 
of benzene along with ethylbenzene and toluene had the highest odds ratio for asthma (38). Choi et al. 
found that the natural-log of summed propylene glycol and glycol ethers in bedroom air was associated 
with a 1.5 fold increase in asthma rates (37).   
Many other exposures are well known triggers of asthmatic response, such as several dust mite, 
bacterial, and fungal species; however, most of these species are not considered risk factors for 
developing asthma in the first place (35). A notable exception to this is the exposure from certain 
bacterial species that release endotoxin upon the death and disintegration of the bacterial cell (35). In 
this instance, high endotoxin concentrations was a significant risk factor for the development of 
wheezing and asthma amongst newborns (35).   
Factors underlying development and exacerbation of asthma are not fully understood, and my 
proposal investigates the role of persistent organic pollutants like PBDEs on asthma. While PBDEs have 
many undetermined effects on asthma pathogenesis, previous research has elucidated the role of other 
POPs, such as polychlorinated biphenyls (PCBs).  High levels of PCB exposure has been epidemiologically 
linked to a high degree of respiratory symptoms, including asthmatic airway phenotype (36). 
Phosphorus flame retardants, which have replaced PBDEs in countries where PBDEs were banned, have 
been found to enhance the odds ratio for asthma development when the chemical TNBP was found on 
the floor or household surfaces (40). 
Many studies have attempted to correlate early childhood PBDE exposure to development of 
asthma, but have been mostly unsuccessful.  For example, one study looked at the levels of PBDE found 
in dust samples collected from the mattresses of children in Stockholm, Sweden. While PBDEs were 
found in the mattresses of asthmatic subjects, the concentrations of PBDE congeners did not vary 
significantly between these subjects and control subjects with no asthma (32). Another case control 
study in Shanghai observed children ages 3 to 6 years old attempting to link their diagnosed asthma to 
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exposure to PBDE and PCB exposure. In this study, 100% of the 124 pooled serum samples contained 
PBDE-47, the chemical of focus for our study, along with many other congeners of the chemical (31). 
These studies together suggest that PBDEs may not cause direct asthma development upon exposure as 
a child, but may lead to sensitization triggering asthma symptoms in children (31). As a result, our study 
focuses on “in-utero” exposures and their impact on early embryonic lung development to determine if 
exposure to PBDE-47 may lead to a priming of asthma. In addition, another proposed mechanism of 
asthma development in response to exposure to PBDEs involves immune system modulation. One clear 
indicator of the involvement of the immune system is the IgE count, a predictor of immune involvement, 
increases in response to PBDE-47 exposure (37). Additionally, in adult PBMCs, it was found that PBDE71 
stimulated high levels of cytokine production, which are increasingly expressed in all types of asthmatic 
lung, particularly allergic asthma (40). A study by Zota et al. found that doubling the concentration 
PBDEs was associated with a 15.26% and 3.74% increase in IL6 and TNFA expression in the blood, 
indicating moderate increase in inflammation response proteins following PBDE exposure (49). The 
TNFA gene produces the inflammatory cytokine TNFA, a protein used in immune inflammation response 
by macrophages and monocytes. TNFA is responsible for a diverse range of signaling events within cells, 
which may lead to necrosis or apoptosis (14). The protein is also important for resistance to infection 
and is involved in many cancer pathways (14). Elevated TNFA levels are highly associated with asthmatic 
phenotype, showing a clear connection between inflammation and asthma. TNFA is involved in lung 
airway smooth muscle cell hyperreactivity; TNFA induces the release of LTC4 and LTD4 mediators along 
with histamine from mast cells, leading to AHR (27). TNFA also increases the cytotoxic effect of 
eosinophils, which are involved in signaling, activation, and migration of T cells to stimulate AHR (27). As 
a result of this altered expression of TNFA in human cells, I wish to investigate further the role of TNFA 
in lung tissue to determine whether it may modulate asthma response in our model. 
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1.5. New direction: Epigenetic Changes Associated with PBDE Exposures 
The effect of PBDEs on gene transcription is strongly associated with an epigenetic mechanism 
of change for gene regulation (9, 12, 17). Epigenetic changes in genes are changes outside of the direct 
DNA sequence that effect expression levels of the gene that may be influenced by both one’s internal 
and external environment. Epigenetic changes include non-coding RNAs, which reduce functionality of 
mRNAs leading to reduced protein production, histone modifications, which are covalent modifications 
to the histone structure that alter transcription of a gene, or DNA methylation, the method of epigenetic 
regulation that my experiment will be investigating (22). DNA methylation is involved in silencing of 
gene transcription, and while there is still debate on the exact mechanism of this silencing, methylation 
may lead to either interference with transcription factor binding, creation of inactive chromatin 
structure, or lead to transcriptional repression complexes (23). DNA methylation can also be heritable, 
leading to epigenetic changes in the progeny of mothers exposed to PBDEs and other environmental 
hazards (24).   
 In addition, it has been postulated that changes to regulation of asthma related genes through 
PBDEs exposure may be caused by epigenetic reprogramming. Epigenetic reprogramming relates to the 
concept of a fetal origin of disease, also known as the “Barker Hypothesis”, which is used to describe 
how the pathogenesis of many chronic illnesses can be traced back to rapid growth periods that occur in 
utero, and can be affected by environmental factors (62, 63).  These rapid growth periods correspond to 
periods of methylation following embryonic genome activation, and alterations in specific genes 
occurring during fetal development. Aberrant epigenetic reprogramming established in utero ultimately 
contributes to disease risk in later life. We previously reported that, using the Boston Birth Cohort, 
maternal exposure to PBDE-47 showed cord blood demethylation of the TNFA gene (9), which would 
lead to cell damage/death by increased inflammation cytokine production. It also speculates that in-
utero exposure to PBDEs may cause overall epigenetic reprogramming in order to alter immune 
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response, leading to hyperreactivity (9). PBDE-47 has also been shown to elicit alterations in global DNA 
methylation patterns within several tissue types, including placenta and brain tissue (28, 65). Other 
mechanisms, such as histone modifications and microRNAs also play a part in the epigenetic regulation 
of genes, and can similarly be affected by environmental toxicants, such as PBDE-47.  
In addition to TNFA, epigenetic regulation of BDNF is associated with PBDE exposure. The BDNF 
protein is primarily used as a growth factor in neurons, influencing activity, function, and survival of 
neurons. BDNF is viewed as a neuroprotective protein, associated with improved prognosis and function 
of neurons in a variety of neurological disorders (8). BDNF  is expressed in the lung; during embryonic 
development, neurons in the developing brain create axons within the lung. These neurons exist within 
the dorsal and ventral respiratory nuclei in the medulla oblongata, and provide parasympathetic 
efferent information and much of the sensory afferent information to the lungs (13). This complex 
neural network helps control breathing, smooth muscle tone, mucus secretion, and trigger coughing 
reflexes (13). BDNF serves as a target-derived neurotrophic factor for airway smooth muscle (ASM) 
innervation by extrinsic neurons during embryogenesis. BDNF is coordinated with ASM differentiation 
for proper innervation.  BDNF is often regulated through miRNAs (particularly miR-206), and is 
downregulated with ASM differentiation (13). Strikingly, TNFA is positively correlated with that of BDNF, 
particularly within ASM cells, demonstrating the direct link that both have in inflammation effects in 
asthma (7). In the presence of inflammatory cytokines, ASM response to BDNF increases, and causes a 
positive feedback loop for BDNF production. This pathway of feed forward BDNF production begins with 
transient receptor potential channels TRPC3/6 receiving elevated levels of [Ca2+] and inducing airway 
smooth muscle BDNF secretion (26).  From here, BDNF binds to its receptor, TRKB, which activates a 
variety of signaling events; pathways that elevate calcium levels further, leading to the positive feedback 
(26). 
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Changes in Bdnf expression have been observed in hippocampal tissues of mice exposed to 
various PBDE congeners (8). Arita et al. also found that basal production of BDNF significantly reduced in 
human placenta exposed to PBDE-47 and 99 (50).  However, epigenetic alterations in Bdnf and Tnfa 
expression in mouse lung as a result of PBDE exposure has not been explored, providing an opportunity 
for us to observe the changes in their expression that may alter asthma risk . 
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CHAPTER 2: Effect of Single Dose Exposure to PBDE-47 on Offspring Asthma Associated Phenotypes 
 
2.1  Abstract 
 The regulation of inflammation related genes has been shown to be affected exposure to PBDE 
congeners, including the most environmentally persistent congener, PBDE-47.  In order to ascertain the 
effect of PBDE-47 on lung inflammation, we investigated the effects of a single dose of PBDE-47 on 
expression of inflammatory genes in mouse lung. Previous studies have suggested there is an 
association between PBDE-47 exposure and the expression of TNFA and BDNF. In the present study, no 
trend was observed between exposure group and gene regulation or promoter methylation for these 
genes in this single-dose model. Perhaps, changes in epigenetic regulation of these genes requires a 
longer period of chemical stressor, which ultimately alter the lung functions as well as airway 
inflammation.  
 
2.2  Introduction 
 Environmental exposure to PBDE species has been speculated to affect gene regulation in 
several genes related to asthma and airway hyperresponsiveness.  In particular, the PBDE species, PBDE-
47, has been cited to alter epigenetic regulation of the genes Bdnf and Tnfa. PBDE-47 is the chosen PBDE 
species due to it being the most persistent of the species and having the highest body burden in humans 
due to its ability to bioaccumulate. Bdnf was found to have reduced nuclear 5-mC methylation after a 
low dose exposure in Rattus norvegicus (11).  Similarly, TNFA had decreased promoter methylation in 
cord blood associated with high maternal PBDE-47 exposure in the human Boston Birth Cohort study (9). 
Strikingly, TNFA promoter methylation showed significantly hypomethylation in young girls whose 
mothers had a high blood PBDE-47 level. 
 These findings are of particular concern when considering its effects on asthma pathogenesis 
and severity. BDNF is associated with innervation of the lungs, and demethylation observed in the rat 
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study could lead to increased production of BDNF in the developing lung, which could cause increased 
airway hyperresponsiveness (AHR). With TNFA, there is concern the cytokines could lead to increased 
inflammation, exacerbating and increasing the severity of asthma symptoms.   
 As a result of these findings, we hypothesized that a single dose of PBDE-47 could upregulate 
the gene expression of Tnfa and Bdnf measured in mouse lung tissue. We further speculated that 
decreased promoter methylation would lead to the increased gene expression. To test this hypothesis, 
we exposed the mice to a 10mg/kg/BW dose in order to ascertain if the exposure can have a direct 
effect on gene promoter. A dose of 10mg/kg/BW was used for this study to replicate the effective dose 
that modulated gene expression in a PBDE study designed by the European Food Safety Commission 
(70)  
 
2.3 Materials and Methods 
Exposure to PBDE-47 
PBDE-47 was purchased from AccuStandard (New Haven, CT). A single dose of 10mg/kg/bw of 
PBDE-47 in corn oil was administrated via oral gavage to 8 weeks old B6S129 mice.  Two weeks after the 
exposure, lung tissue was then collected and snap-frozen for gene expression analysis. 
RNA and DNA Isolation 
DNA and RNA were extracted from mouse lung tissue utilizing the AllPrep Universal Kit (Qiagen). 
Lysate from the lung samples are passed through a DNA spin column to selectively isolate DNA then on a 
RNeasy spin column to selectively isolate RNA. Quality of DNA and RNA was accessed by the analysis of 
the two wavelengths (260nm and 280nm) used for UV-Vis absorbance measurements via the Epoch 
Take3 Microplate Spectrophotometer (BioTek). Only the RNA samples showing a ratio of 1-8-2.0 and the 
DNA samples showing a ratio of 1.5-1.7 were utilized in the gene expression and methylation studies. 
12 
 
Quantity was also determined using the UV absorbance reading. These isolated samples were then 
stored at 4oC (DNA) and -80oC (RNA) until further use. 
Gene Expression via qPCR 
cDNA used for measurement of gene expression was made from one thousand ng of RNA 
extracted from mouse lung using the iScript cDNA synthesis kit (Biorad).  Primer sequences are as 
follows: mBdnf-2: Forward sequence: CAT AAG GAC GCG GAC TTG TAC A, Reverse sequence: AGA 
CAT GTT TGC GGC ATC CA.  mTnfa-m1: Forward sequence: AGC CGA TGG GTT GTA CCT TG, 
Reverse sequence: ATA GCA AAT CGG CTG ACG GT. mRNA levels were measured by the SYBR-Green 
based real time PCR performed at AB7500 Fast qPCR machine (Applied Biosystems). The 2 -ΔΔCt method 
was used to calculate relative expression levels through a comparison to an Rpl19 loading control 
normalization. 
Methylation-specific PCR (MS-PCR).  
Two hundred ng of genomic DNA was used for bisulfite conversion using EZ DNA Methylation kit 
(Zymo Research, Irvine, CA). Bisulfite treated samples were compared to a 100% methylated control 
group to confirm if there was changes in methylation patterns seen by band intensity in the region of 
interest, as determined by the primers used. Primer sequences specific for the methylated DNA 
sequence of the Bdnf promoter used for this study are as follows: mMS-Bdnf-c1: Forward sequence: 
CGG GAA GTA TTT AAA ATA GGG TAG C, Reverse sequence: CTA ATA ACT AAA CGA AAA ACA 
CCC G.   
Statistical Analysis.  
Data are expressed as mean ± SEM using a t-test or one way ANOVA with Tukey’s multiple 
comparisons test. Statistically significant was defined as p< 0.05 using GraphPad Prism v7 software (La 
Jolla, CA).  
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2.4  Results and Discussion 
In order to determine the epigenetic effect of PBDE-47 on lung inflammation, I followed up with 
a measurement of promoter methylation and mRNA levels of the inflammatory genes, Bdnf and Tnfa, to 
see if there was any correlation between observed gene expression and promoter methylation.   
The relative expression data acquired via qPCR showed no difference between the control 
samples and PBDE exposed mice (Table 1).  Despite the reduction in gene expression (Bdnf reduction of 
~19% and Tnfa reduction of ~18%) that was measured from the samples, the p values were high 
suggesting that PBDE-47 did not affect both gene expression of Bdnf and Tnfa. On the other hand, the 
promoter demethylation, usually correlates with an increased gene expression measured if DNA 
methylation contributes to regulation of gene transcription. Take Bdnf as an example, the methylation 
data obtained following bisulfite treatment and MSPCR did not show any difference in promoter 
methylation. Also, there was no correlation between DNA methylation and gene expression.  
The results displayed (Tables 1 and 2) currently contradict the findings seen in the rat nuclear 
gene study conducted by Byun et al, where they found significant changes in the regulation of Bdnf.  
Additionally, Zota et al found a dose dependency, where doubling the concentration of PBDE would lead 
to a 3.74% increase in Tnfa expression, and this trend of a dose response is not tested here. Most likely, 
it suggests that one single dose of PBDE does not necessarily result in a statistically significant 
phenotypic difference in asthma related genes. Our previous study demonstrated that the maternal 
exposure to PBDE-47 study was associated with the demethylation in the promoter of TNFA in cord 
blood in humans (9, 11). Similarly, increasing Bdnf expression was shown in other study in which the 
animals were administrated PBDE-47 during post-natal lung development, it is possible that Bdnf, which 
is most active as a growth factor for ASM during embryogenesis (13). Taken together, it suggests that 
epigenetic impact on gene regulation through PBDE-47 may require more specific dosing during critical 
windows of exposure. Early life exposures to chemical stressors impacts the later life asthma risk, at 
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least through epigenetic modulation of the genome. In order to fully ascertain the effects of PBDE-47 on 
gene expression and methylation, I followed up the single dose experiment by exposing a new cohort of 
mice to repeated doses of PBDE-47, as described in Chapter 3.   
 
Table 1:  Effect of PBDE-47 on gene expression in Bdnf and Tnfa in mouse lung  
 
Gene Oil (RER, SEM) PBDE (RER, SEM) 
 
P value vs. Oil control 
    Bdnf 0.78, 0.22 0.63, 0.12 0.55 
    Tnfa 0.63, 0.09 0.52, 0.09 0.40 
 
Note: Gene expression was examined by real-time PCR and normalized to the housekeeping gene, Rpl19. Relative 
Expression Ratio (RER) values were calculated by a 2-ddCt method, in which RER was assigned a value of 1.00 for 
mouse universal RNA. Data were shown as mean values ± SEM (n=3-12). An unpaired parametric t-test was used to 
achieve these values. 
 
Table 2:   Effect of PBDE-47 on promoter methylation of Bdnf     
Gene Oil (Met%, SEM) PBDE (Met%, SEM) 
 
P value vs. Oil control 
    Bdnf 10.50, 6.33 9.96, 4.94 0.94 
 
Note: Percent of methylation (Met%) was determined by MS-PCR as the ratio of the sample’s methylation 
percentage relative to a fully methylated DNA control. Data were shown as mean values ± SEM (n=3-12). An 
unpaired parametric t-test was used to achieve these values. 
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CHAPTER 3: Effect of Multi Dose Exposures on Offspring Asthma Associated Phenotypes 
 
3.1  Abstract 
 Following completion of the single dose PBDE experiment and observing no change in 
experimental vs control animals, a model in which mice exposed to multiple PBDE exposures in utero  
was developed to see the epigenetic effect of PBDE-47 on mouse lung genome when administered at 
several timepoints such as pre-conception, fetal lung development, and postnatal lung development. 
Following dosing, the epigenetic effect of PBDE on gene transcription of Tnfa, Bdnf, the asthma related 
genes, was tested in lung of  F1 offspring when they reached adulthood. In addition, we determined if 
the epigenetic effect of early life exposures to PBDE on offspring’s lung genome was further enhanced in 
mice received an additional administration of house allergens, which is known to induce allergen-
induced airway hyperresponsiveness.  Overall, the data suggests that maternal PBDE exposure impact 
the methylation of genes related to inflammatory pathways, which supports the hypothesis that 
epigenetic regulation of asthma pathogenesis in response to PBDE in an experimental asthma model. 
 
3.2  Introduction 
Environmental exposure to PBDE species has been speculated to affect gene regulation in 
several genes related to immune responses and asthma. As mentioned previously in chapter 2, the PBDE 
species, PBDE-47, has been cited to alter epigenetic regulation of the genes BDNF and TNFA (9, 11). 
These findings are of particular concern when considering its effects on asthma pathogenesis and 
severity. The BDNF protein is associated with innervation of the lungs, and demethylation observed in 
the rat study could lead to increased production of BDNF in the developing lung, which could cause 
increased hyperresponsiveness. With the cytokine TNFA, there is concern the cytokines could lead to 
increased inflammation, exacerbating and increasing the severity of asthma symptoms.   
 As a result of these findings and following the result of the single dose experiment where no 
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change was found after a one time dose was administered, we hypothesized that multiple doses of 
PBDE-47 through various points of development and epigenetic reprogramming would modulate the 
gene expression of Tnfa and Bdnf measured in lung tissue. We expected that this upregulated gene 
expression would be associated with decreased promoter methylation, which would ultimately 
contribute to the increased airway inflammation seen in asthmatics.  To test this hypothesis, mice were 
exposed to PBDE during pre-conception, and the F1 mice exposed to 0.1 mg/kg/bw PBDE in utero and 
postnatally to ascertain if exposures at these specific timepoints could have epigenetic effect on the 
asthma related genes. These dose amounts were also chosen to replicate values similar to the median 
concentration of PBDE-47 found in human cord blood (11ng/g lipid BW) (9) and the benchmark dose of 
0.47mg/kg seen in the rodent neurotoxicity study (66). 
 
3.3  Materials and methods 
Exposure to PBDE-47 and House Dust Mite (HDM) 
0.1 mg/kg/bw of PBDE-47 or corn oil (as control) was administered to 7-week old adult mice at 
five critical windows (2 weeks before conception to prime the immunity setup, 1st and 2nd week of 
gestation for in utero epigenetic reprogramming, and 4th and 16th day of lactation for postnatal lung 
development) via oral gavage. Breeding pairs were established as 2 females with 1 male (B6S129SF1/J). 
The offspring were separated from dams after weaning. Among them, half of the eight-week-old 
offspring from each dam (F0-Saline, F0-PBDE)were subjected for HDM challenge to induce airway 
hyperresponsiveness. The mice were first sensitized with an intraperitoneal injection of 100 µg HDM 
containing 0.53EU endotoxin in sterile phosphate buffered saline (PBS) or PBS only (as a control). Two 
weeks after, the offspring were challenged by 100µg of HDM with 0.53EU endotoxin or PBS 3 times a 
week intratracheally. Two days after the last challenge, the mice were anesthetized with 1:1 
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ketamine:xylazine, paralyzed with succinylcholine, and maintained on a ventilator to assess AHR 
followed by tissues harvesting.  
Reduced Representation Bisulfite Sequencing 
Reduced representation bisulfite sequencing (RRBS) is a method of determining genome wide 
methylation profiles. This method of sequencing uses highly methylation specific restriction enzymes to 
hone in on specific regions of the genome with methylation, particularly within gene promoters. This has 
the advantage of pinpointing genome locations of specific interest, those with higher methylation, at a 
cheaper price and faster rate than comparable techniques such as whole genome bisulfite sequencing 
(WGBS). This method allows us to see if epigenetic gene regulation can alter disease susceptibility 
through altering gene expression, but at the cost of overlooking non-promoter regions that can be 
analyzed using WGBS. 
Our RRBS-Seq study used the following protocol: The Genomic DNA extracted from lung tissues 
using the protocol described in 2.3.2 underwent MspI digestion (NEB) and bisulfite treatment (Zymo) 
before undergoing DNA library synthesis and then pair ended at Hi-Seq4000 (at 50-70M read pairs per 
sample).  FASTQ files obtained from the RRBS-Seq study were imported into CLC BioMedical Workbench 
version 4.0 with the default import settings. Pair-ended reads were counted, trimmed and quality 
checked prior next step. After basic data preparation (Prepare Raw Data), quality reads were mapped to 
the Mus musculus Ensembl v80 Reference Sequence with bisulfite sequencing specific algorithm. Reads 
mapped to the mice genome were further “soft-clipped 5 bases” before the comparison analysis to 
remove methylation detection bias presumably due to end repair process in library preparation. A total 
of 403 peak reads showing differentially methylated (p<0.05, fold difference in methylation level >2) 
were identified. We next annotated these peak reads to genes and mapped the differential methylated 
genes to biological networks by panther pathway analysis. The top three pathways were enriched in 
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WNT signaling pathway (mapped genes: 11); Gonadotropin-releasing hormone receptor pathway 
(mapped genes: 10) and Inflammation mediated by chemokine and cytokine signaling pathway (mapped 
genes: 8). Among these 29 genes, some of them are mapped for more than one pathway. In silico 
analysis was done to examine if there are CpG islands at the 5’regulatory region (-2000 to +2000 from 
TSS) of these methylated gene candidates. A list of seven genes with 5’ CpG island(s) was chosen to test 
the hypothesis that the gene expression altered by maternal PBDE-47 exposure could contribute to lung 
inflammation and associate with the increased HDM-induced AHR in offspring. 
Other Methods 
 Gene expression analysis, methylation specific PCR, and statistical analyses were performed as 
outlined in chapter 2.3. Sequences of primers used for gene expression and methylation studies listed in 
Table 1 and 2. This analysis was carried out on the male mice only.  
 
Table 3:  MSPCR primers for Tnfa and Bdnf 
         Primer List (Sequence 5’ to 3’’) 
 
           mMS-Bdnf-C1F CGG GAA GTA TTT AAA ATA GGG TAG C 
              
           mMS-Bdnf-C1R CTA ATA ACT AAA CGA AAA ACA CCC G 
 
          mMS-Tnfa-MF1                          AAT TTT TTA AAT TTT TTG TTT TCG C 
 
          mMS-Tnfa-MR1                         TAA CTA ATC CCT TAC TAT CCT CGC T 
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Table 4:  qPCR primer list for RRBS genes 
 
Primer Name Gene Name Sequence (5’ to 3’) 
 
mAdcy2-F1 
 
Adenylate cyclase 2 
 
CGG ATG TGC CAA TGG GTC AA 
 
mAdcy2-R1 
 
Adenylate cyclase 2 
 
GCC ATT GCT TTT GTG CGT TG 
mItpr3-F1 Inositol 1,4,5-triphosphate receptor 3 GCT GTC AAC ATG AGC GAC CT 
mItpr3-R1 Inositol 1,4,5-triphosphate receptor 3 GAC ACG CGG CCT TTG GT 
mPcdh1-F1 Protocadherin 1 GAG AAG GTG AGG ACT AGG GC 
mPcdh1-R1 Protocadherin 1 AAT CAG GAG AAC TTC TGG GTT GTC 
mPparg-F1 Peroxisome proliferator-activated receptor gamma CTG ACG GGG TCT CGG TTG 
mPparg-R1 Peroxisome proliferator-activated receptor gamma AAC CAT GGT AAT TTC AGT AAA GGG T 
mPtk2-F1 Protein tyrosine kinase 2 TGC CCT CGA CCA GGG ATT AT 
mPtk2-R1 Protein tyrosine kinase 2 AAG CTG GAT TCT CTG GGC TC 
mSfrp1-F1 Secreted frizzled-related protein 1 GAA GCC TCT AAG CCC CAA GG 
mSfrp1-R1 Secreted frizzled-related protein 1 ATC CTC AGT GCA AAC TCG CT 
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mSiah1b-F1 Siah E3 ubiquitin protein ligase 1B AGG GCG GGT CAG GAG TCA A 
mSiah1b-R1 Siah E3 ubiquitin protein ligase 1B ACC TGG TCT TCC CAA GTT TCC A 
mSocs5-F1 Suppressor of cytokine 5 signaling AGG CTC TCG AAG GCT CAG G 
mSocs5-R1 Suppressor of cytokine 5 signaling TGA TTA GAA GAG CTC CAC GGC 
 
3.4 Results and Discussion 
To demonstrate if maternal PBDE exposures contributes to asthma pathogenesis, we 
determined if the effects of PBDE exposure at multiple timepoints during mouse lung development 
affected the gene expression of select genes related to asthma pathogenesis. When looking at the two 
focal genes of the study, Bdnf and Tnfa, both genes show a strong upwards trend in gene expression 
between the maternal oil control (F0-Oil_F1-Saline) and PBDE exposed (F0-PBDE47_F1-Saline) groups 
without the adult exposure to HDM (Figure 1 and Table 3). Over a two fold increase in average gene 
expression of Bdnf between the F0-Oil_F1 PBS and the F0-PBDE_F1-PBS was seen, although the changes 
is not statistically significant. We additionally observed over a two fold increase in average Tnfa mRNA 
levels between F0-Oil_F1-Saline and the F0-PBDE_F1 Saline, but this observed difference is also not 
statistically significant. Upon the adult exposure to HDM, the group with PBDE exposed F0 mothers 
showed a trend of further increase in Bdnf and Tnfa expression (F0-Oil_F1-HDM vs the F0-PBDE_F1-
HDM). 
While the observed difference in gene expression of Bdnf and Tnfa was not found to be 
significant, we did find a clear trend in increased expression of these pro-inflammatory genes.  Both of 
these gene expression upregulations correlated well with the observed decreased promoter methylation 
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(Figure 2). Results indicates that maternal exposure to PBDE with or without adult HDM exposure 
caused demethylation of Bdnf and Tnfa promoters that resulted in the increased gene expression. A 
reduction in CpG on a promoter could organize the chromatin to unwind and make these pro-
inflammatory genes become transcriptionally active. We speculate the increase in Bdnf and Tnfa could 
contribute to the asthma-related phenotypes, ASM innervation and inflammation respectively, which 
gives them plausibility as driving genes for asthma that PBDE-47 can act on.  
 
A.                             B. 
       
Figure 1:  Effect of maternal PBDE-47 exposure and adult HDM exposure on gene expression 
of Bdnf and Tnfa.  Relative gene expression (RER) ratios for Bdnf (A) and Tnfa (B) were observed in F1 
offspring.  The transcription levels of Tnfa and Bdnf were examined by real-time PCR and normalized to 
the housekeeping gene, Rpl19. Relative Expression Ratio values were calculated by a 2-ddCt method, in 
which RER was assigned a value of 1.00 for mouse universal RNA. Data were shown as mean values ± 
SEM. 
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Table 3:  Statistical analysis of the effect of PBDE and HDM on gene expression of Bdnf and 
Tnfa 
 
Gene F0 Oil_F1 PBS (A) 
Mean,  SEM 
F0 Oil_F1 HDM (B) 
Mean,  SEM, P value vs (A) 
F0 PBDE_F1 PBS (C) 
Mean,  SEM, P value vs (A) 
F0 PBDE_F1 HDM (D) 
Mean,  SEM, P value vs (B), P value vs (C) 
Bdnf 2.39       0.55 1.07     0.10     0.64 5.13     1.18    0.09 2.42    0.59     0.56     0.06 
Tnfa 0.32     0.14 1.19     0.11    0.49 0.74    0.21   0.89 1.73    0.33     0.59      0.10 
 
Note: Relative gene expression ratios for Bdnf (A) and Tnfa (B) observed in F1 offspring. The transcription levels of 
Tnfa and Bdnf were examined by real-time PCR and normalized to the housekeeping gene, Rpl19. Relative 
Expression Ratio values were calculated by a 2-ddCt method, in which RER was assigned a value of 1.00 for mouse 
universal RNA. Data were shown as mean values ± SEM. Statistical analyses conducted were ordinary one-way 
ANOVAs with Tukey’s multiple comparisons.   
A.                  B. 
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Figure 2:  Effect of maternal PBDE-47 exposure and adult HDM exposure on promoter 
methyation of Bdnf and Tnfa.  Methylation percentages for Bdnf (A) and Tnfa (B) were observed in 
F1 offspring. Percent of methylation reference was determined by MS-PCR as the ratio of the sample’s 
methylation percentage relative to a fully methylated DNA control. An ordinary one-way ANOVA with 
Tukey’s multiple comparisons. * = P<0.05. 
 
 
Table 4:  Statistical analysis of the effect of PBDE and HDM on promoter methylation of Bdnf 
and Tnfa 
 
Gene F0 Oil_F1 PBS (A) 
Mean%,  SEM 
F0 Oil_F1 HDM (B) 
Mean%,  SEM, P value vs (A) 
F0 PBDE_F1 PBS (C) 
Mean%,  SEM, P value vs (A) 
F0 PBDE_F1 HDM (D) 
Mean%,  SEM, P value vs (B), P value vs (C) 
Bdnf 76.1      6.45 77.5      7.43     0.99 62.9     4.72     0.39 52.2      5.00     0.03      0.51 
Tnfa 77.3     4.70 68.7      8.61     0.89 43.5     11.1     0.05 50.7      7.29     0.40        0.92 
 
Note: Methylation percentages for Bdnf and Tnfa were observed in F1 offspring. Percent of methylation reference 
was determined by MS-PCR as the ratio of the sample’s methylation percentage relative to a fully methylated DNA 
control. An ordinary one-way ANOVA with Tukey’s multiple comparisons. Bold indicates statistical significance. 
In addition to the analysis of genes related to asthma pathogenesis, we applied an unbiased 
genome-wide methylation profiling to identify other epigenetic changes induced by PBDE exposure. 
After completion of a reduced representation bisulfite sequencing (described above in 3.3) we identified 
differential methylation of genes outside of the primary focus of Tnfa and Bdnf : Adcy2, Ascl1, Itpr3, 
Pparg, Ptk2, Sfrp3, Siah1, and Socs5. Briefly, Adenylate cyclase 2 (Adcy2) encodes for an adenylate 
cyclase, which is a membrane associated enzyme involved in the catalyzing the formation of cyclic 
24 
 
adenosine monophosphate (cAMP). cAMP is important in the regulation of airway smooth muscle cells, 
cells which are inextricably linked to asthma, becoming contracted and inflamed during an asthmatic 
episode (55). Ascl1 (Achaete-Scute Family BHLH Transcription Factor 1) is involved in the differentiation 
of pulmonary neuroendocrine cells and other autonomic neurons. As a result, it plays a key role in the 
innervation, and therefore sensitization, of the lung (56). Itrp3 (Inositol 1,4,5-triphosphate receptor 3) 
encodes for a receptor on inositol 1,4,5-triphophate, which serves as a second messenger for calcium 
regulation. It was recently found to be dysregulated in asthma in a male-specific manner (57). Pparg 
(Peroxisome proliferator-activated receptor gamma) is a ligand activated transcription factor involved in 
the regulation of adipocyte differentiation and glucose homeostasis. It also upregulates PTEN, which can 
negatively modulate allergic inflammation in asthma (58). Ptk2 (Protein tyrosine kinase 2) may be 
important in early cell growth and intracellular signal transduction pathways in response to neural 
peptides or interactions with extracellular matrix, meaning it also plays a role in early innervation of the 
lung (60). Sfrp1 (Secreted frizzled-related protein 1) is a modulator of the Wnt signaling pathway, and 
epigenetic silencing of Sfrp1 has been implicated in allergic asthma by altering airway inflammation and 
lung function (59). Siah1 (Siah E3 ubiquitin protein ligase 1B) encodes for a protein involved in 
proteasome mediated degradation in the neuron, and is also highly expressed in the lung (60). Finally, 
Socs5 (Suppressor of cytokine 5 signaling) is involved in cytokine signaling as negative regulators of the 
signaling pathway; where epigenetic silencing could lead to increased cytokine related inflammation in 
the lungs (61). Taken together, we demonstrated maternal exposure to PBDE could alter lung 
methylome, which may ultimate alter development of asthma. 
 To determine if the methylation patterns induced by PBDE exposure contribute to the gene 
expression, we applied qPCR to measure the mRNA level of the genes identified from RRBS (Figure 3 and 
Table 5). No trend was observed in Adcy2 was seen between the F0-Oil_F1-PBS and the F0-PBDE47_F1-
PBS, or between the F0-Oil _F1-HDM and the F0- PBDE47_F1-HDM. This result suggests that there is 
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little effect to Adcy2, which is responsible for increasing production of cAMP, which activates protein 
kinase A, leading to a relaxation of ASM (67). With the gene Itrp3, No trend was observed between the 
F0-Oil_F1-PBS and the F0-PBDE47_F1-PBS, and a weak trend was seen between the F0-Oil _F1-HDM and 
the F0- PBDE47_F1-HDM (p = 0.32). However,  Itrp3 did have a greater than eight-fold increase in 
expression F0-PBDE47_F1-PBS and the F0-PBDE47_F1-HDM. This somewhat corresponds with the 
findings seen in Gautam et al, where there was a sex specific increase in male Itrp3 expression amongst 
asthmatics, suggesting it could have influence in asthma amongst men (57). However, the gene is far 
more strongly modulated by the HDM exposure than the PBDE47 exposure. Pparg also had no trend 
between the F0-Oil_F1-PBS and the F0-PBDE47_F1-PBS, or the F0-Oil_F1-HDM and the F0- PBDE47_F1-
HDM. When comparing the differences between the F1-PBS and F1-HDM groups, the gene had around a 
seven-fold reduction in expression for both F0-Oil and F0-PBDE subgroups. Pparg’s knockdown has been 
cited by Nieto et al to cause a global upregulation of pro-inflammatory genes specifically involved with 
immune cell proliferation and migration, but is only significantly modified by HDM (68). Ptk2 also saw no 
trend in between the F0-Oil_F1-PBS and the F0-PBDE47_F1-PBS, or between the F0-Oil _F1-HDM and 
the F0- PBDE47_F1-HDM. When looking at HDM exposure, Ptk2 was upregulated six-fold in our model 
when comparing F0 PBDE_F1 PBS and the F0 PBDE_F1 HDM, has been seen to correlate with childhood 
asthma, and could play a similar role as Bdnf in lung cell innervation. Sfrp3’s gene expression data had 
no trend in between the F0-Oil_F1-PBS and the F0-PBDE47_F1-PBS, or between the F0-Oil _F1-HDM and 
the F0- PBDE47_F1-HDM.  Sfrp1, which is highly expressed in allergic asthma and alters airway 
inflammation, increased three-fold in the male mice when adding the allergen modification of HDM 
exposure within the oil and PBDE subgroups.   
Siah1, which is seen as a marker of neuron regulation in allergic asthma, was only modified through 
HDM exposure.  When comparing the F0-Oil_F1-PBS and the F0-PBDE47_F1-PBS, or the F0-Oil _F1-HDM 
and the F0- PBDE47_F1-HDM, there was no difference observed. Finally, Socs5 saw almost a four-fold 
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decrease between the F0-Oil_F1-PBS and the F0-PBDE_F1-PBS. Albeit not statistically significant 
(p=0.08), this increase observed would indicate increased cytokine signaling, increasing inflammation 
response in asthma.   
Of note in this study is that for many of the genes RRBS gene list, HDM served as a much 
stronger modifier of gene expression than PBDE-47 exposure did (such as Pparg, Ptk2 and Sfrp1). HDM is 
a strong inducer of allergic response, so while this is expected, observed gene expression changes was 
also expected to be correlated with PBDE-47, based on the results of the RRBS. Two reasons most likely 
exist for this discrepancy between the RRBS and the collected data. The first is that these genes are 
epigenetically modified through a mechanism other than through 5mC methylation, which could be 
overriding potential methylation observed.  Examples of this include low RNA stability, which could lead 
to low observed transcription level.  Other possibilities include alterations in binding of transcription 
factors or the binding of histones, which could interfere with transcription despite methylation status 
changing. Finally, induction of miRNAs could also degrade higher RNA we would otherwise measure. 
Outside of an epigenetic rationale, some trends observed may be confirmed to be significant with a 
higher sample size, particularly in the genes Bdnf, Tnfa, Itpr3, and Socs5. Being limited to smaller sample 
sizes, especially ones with outliers that overlap in value with another subgroup as seen in our data, 
make it difficult to obtain results of statistical significance. 
 Overall, the data suggests that maternal PBDE exposure impacts the methylation of genes 
related to inflammatory pathways, such as Bdnf and Tnfa, as well as alter gene expression in certain 
genes, such as Bdnf, Tnfa, Itpr3, and Socs5.  This supports the hypothesis that epigenetic regulation of 
asthma pathogenesis in response to PBDE in an experimental asthma model. More data needs to be 
obtained to see whether similar methylation alterations can be observed in other genes modified by 
PBDE-47 exposure. 
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Figure 3:  Effect of maternal PBDE-47 exposure and adult HDM exposure on mRNA level of 
Differential Methylated Genes Identified from RRBS.  Relative gene expression ratios for Adcy2 
(A),  Itpr3  (B), Pparg (C), Pcdh1 (D), Ptk2 (E), Sfrp3 (F), Siah1 (G), Socs5 (H) were observed in F1 offspring.  
The transcription levels of gene of interests were examined by real-time PCR and normalized to the 
housekeeping gene, Rpl19. Relative Expression Ratio (RER) values were calculated by a 2-ddCt method, 
in which RER was assigned a value of 1.00 for mouse universal RNA. Data were shown as mean values ± 
SEM. Statistical analyses conducted were ordinary one-way ANOVAs with Tukey’s multiple comparisons.  
* = P<0.05, ** = P<0.01, *** = P<0.001,  **** = P<0.0001. 
 
 
Table 5:  Statistical analysis of the effect of PBDE and HDM on promoter methylation of 
differential methylated genes identified from RRBS  
 
    Gene F0 Oil_F1 PBS (A) 
Mean,  SEM 
F0 Oil_F1 HDM (B) 
Mean,  SEM, P value vs (A) 
F0 PBDE_F1 PBS (C) 
Mean,  SEM, P value vs (A) 
 F0 PBDE_F1 HDM (D) 
Mean,  SEM, P value vs (B), P value vs (C) 
Adcy2 0.25     0.06 0.41     0.04     0.88 0.07    0.02    0.82 0.61     0.28       0.80     0.08   
Itpr3 1.52        0.54 2.02    0.40    >0.99 0.72      0.171      0.98 6.05       2.44       0.32       0.05 
Pparg 1.31        0.13 0.18   0.03   <0.0001# 1.06      0.20     0.56 0.170      0.04      >0.99     <0.001# 
Ptk2 0.68   0.09 2.00     0.39    0.10 0.31    0.05    0.89 1.95       0.51      >0.99      <0.01# 
Sfrp1 0.21     0.038 0.64    0.09    <0.001# 0.20     0.03    >0.99 0.69     0.09    0.98    <0.0001# 
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Siah1 0.26      0.05 1.14    0.08     0.10 0.24     0.09     >0.99 0.98    0.35     0.96     0.17 
Socs5 2.42  0.54 1.02      0.27      0.29 0.65     0.305     0.08 0.85      0.314     >0.99     0.99 
 
 
Note: Gene expression was examined by real-time PCR and normalized to the housekeeping gene, 
Rpl19. Relative Expression Ratio values were calculated by a 2-ddCt method, in which RER was assigned 
a value of 1.00 for mouse universal RNA. Data were shown as mean values ± SEM. Statistical analyses 
used were ordinary one-way ANOVAs with Tukey’s multiple comparisons. Adcy2: Adenylate cyclase 2. 
Itpr3: Inositol 1,4,5-triphosphate receptor 3. Pcdh1: Protocadherin 1. Pparg: Peroxisome proliferator-
activated receptor gamma. Ptk2: Protein tyrosine kinase 2. Rpl19: ribosomal protein L19. Sfrp1: Secreted 
frizzled-related protein 1. Siah1: Siah E3 ubiquitin protein ligase 1B. Socs5: Suppressor of cytokine 5 
signaling. # indicates statistical significance. 
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CHAPTER 4:  Discussion, Implications and Future Directions 
In this study, our mouse model was able to demonstrate the ability of PBDE-47 in 
mediating epigenetic changes underpinning altered gene expression in the genes Tnfa and 
Bdnf. The goal of this study was to fill the black box between PBDE exposure and asthma, given 
no confirmed mechanism of toxic action. From the results found in our study, an epigenetic 
mechanism of action for the primary genes of interest is plausible. While more remains to be 
done to confirm our findings, it can be reasonable to assume there is an epigenetic element of 
regulation from PBDE-47 exposure in important asthma related genes. 
Given the understanding that upregulated Tnfa and Bdnf, caused through PBDE-47 
exposure are implicated in asthma phenotype, it becomes even more critical to recommend 
protection from PBDEs during pregnancy, as exposure during this window of susceptibility, 
based on this study, is likely to modulate asthma risk. This can come with the recommendation 
to avoid using furniture imported from countries without pentaPBDE bans, and avoid using 
furniture made in the U.S. before 2005, when the manufacturing of products containing penta 
and octa-PBDE species was banned. The data suggests that U.S. law regarding PBDE species 
should be updated to become more similar to laws already adopted in the European Union, 
where there is already full bans on all PBDE species and bans on recycling of products that 
could contain PBDEs, due to PBDEs’ persistent nature in the environment. 
Experimentally, the next step forward for the multi-dose PBDE model is to investigate 
other genes included in the RRBS study and observe if their promoter methylation changes 
matches their gene expression, particularly in the genes with statistical significance (Adcy2, 
Itpr3, Pparg, Ptk2, Sfrp1 and Siah1). Following up with promoter methylation data for these 
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genes would strength the argument of epigenetic control of asthma related response due to 
PBDE exposure. Additionally, since our multi dose experiment focused on exposing during 
multiple points of development, it is unclear whether or not every point of exposure truly had 
an impact on the final outcomes of gene expression and methylation. Parsing out which points 
are most important, or if it truly requires every dose administered, is the next logical step for 
follow up experiments. In particular, we could separate each major exposure timepoint: pre-
conception, in utero, and post natal, to see which have the largest impact or if each dose is 
needed.  Since Chapter 2 already begins to discuss the effect of post natal exposure during lung 
development, I think looking at in-utero exposures on its own would be most appropriate, 
exposing during 1st and 2nd week of gestation only. Further, it could be useful to determine 
whether any of the gene expression and promoter methylation was modified by factors such as 
sex and genetic background (those with high asthma risk or genetic knockout of inflammatory 
genes). This would be important to ascertain if their were confounding factors that caused 
specific genes and promoter regions to show significant changes. Finally, we could also alter the 
dosage amounts, to see if there is a threshold dosage for epigenetic effects or if even miniscule 
doses can lead to a larger adverse health outcome.  This would help with determining the level 
of control needed over these chemicals from a regulatory standpoint. 
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